Andrew P.

Andrew P. has a diverse work experience in the field of business development and research. Andrew is currently serving as the Vice President of Business Development at Virscio since April 2023. Prior to this, they worked at The Jackson Laboratory as the Director of Corporate & Commercial Development and later as the Regional Director of Opportunity & Business Development from April 2020 to April 2023. From May 2018 to April 2020, they were the Head of Business Development-Cardiovascular and Metabolic Disease North America & EU at Crown Bioscience, Inc. Before that, they held various positions at AIT Bioscience, GenScript, Temple University, Universit\u00e0 di Siena, SHRO, and Weill Cornell Medicine, where they gained experience as an Associate Director of Business Development, Business Account Manager, Post Doctoral Research Fellow, PhD Graduate Student, PhD Student, and Research Fellow respectively.

Andrew P. completed their Bachelor's degree in Biology at Hofstra University from 1998 to 2003. Andrew then pursued further education at Università degli Studi di Siena from 2004 to 2009, where they obtained a Ph.D. in Medical Biotechnology with a specialization in Cellular and Molecular Biology.